The introduction of new vaccines into developing countries

被引：78

作者：

Mahoney, RT ^{[1
]}

Maynard, JE

机构：

[1] Int Vaccine Inst, Seoul, South Korea

[2] Seoul Natl Univ, Int Task Force Hepatitis B Immunizat, Seoul 151742, South Korea

[3] Program Appropriate Technol Hlth, Seattle, WA USA

[4] Int Task Force Hepatitis B Immunizat, Seattle, WA 98104 USA

来源：

VACCINE | 1999年 / 17卷 / 7-8期

关键词：

vaccine introduction; hepatitis B; developing countries;

D O I：

10.1016/S0264-410X(98)00246-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The development and introduction of new vaccines is a costly and time consuming process. Unfortunately, those most in need -individuals in developing countries- are the last to receive these powerful disease preventing products. From the time a vaccine is first licensed in a developed country to the time most of the poor ill developing countries have access to the vaccine can be 20-30 years. This delay is unacceptable. There is a great need to reduce this time span. This paper examines five ways of reducing the time span. Each of the five is essential and achieving success on all five will require a heightened level of international effort and coordination. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：646 / 652

页数：7

共 50 条

[1] Paving the way for the introduction of new vaccines into developing countries
Chabalgoity, JA
[J]. EXPERT REVIEW OF VACCINES, 2005, 4 (02) : 147 - 150
[2] The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries?
Mahoney, Richard
[J]. VACCINE, 2014, 32 (08) : 904 - 908
[3] Thinking downstream to accelerate the introduction of new vaccines for developing countries
Clemens, JD
[J]. VACCINE, 2003, 21 : S114 - S115
[4] The introduction of new vaccines into developing countries II. Vaccine financing
Mahoney, RT
Ramachandran, S
Xu, ZY
[J]. VACCINE, 2000, 18 (24) : 2625 - 2635
[5] The introduction of new vaccines into developing countries - IV: Global access strategies
Mahoney, Richard T.
Krattiger, Anatole
Clemens, John D.
Curtiss, Roy, III
[J]. VACCINE, 2007, 25 (20) : 4003 - 4011
[6] The introduction of new vaccines into developing countries - III. The role of intellectual property
Mahoney, RT
Pablos-Mendez, A
Ramachandran, S
[J]. VACCINE, 2004, 22 (5-6) : 786 - 792
[7] Introducing new vaccines in developing countries
Kochhar, Sonali
Rath, Barbara
Seeber, Lea D.
Rundblad, Gabriella
Khamesipour, Ali
Ali, Mohammad
[J]. EXPERT REVIEW OF VACCINES, 2013, 12 (12) : 1465 - 1478
[8] Introduction of rotavirus vaccines in developing countries: remaining challenges
Cunliffe, Nigel
Nakagomi, Osamu
[J]. ANNALS OF TROPICAL PAEDIATRICS, 2007, 27 (03): : 157 - 167
[9] New Vaccines for Developing Countries: Will it be Feast or Famine?
Andrus, Jon Kim
de Quadros, Ciro
Matus, Cuauhtemoc Ruiz
Luciani, Silvana
Hotez, Peter
[J]. AMERICAN JOURNAL OF LAW & MEDICINE, 2009, 35 (2-3) : 311 - 322
[10] APROPOS "NEW VACCINES FOR DEVELOPING COUNTRIES: WILL IT BE FEAST OR FAMINE?
Arya, Subhash C.
Agarwal, Nirmala
[J]. AMERICAN JOURNAL OF LAW & MEDICINE, 2009, 35 (04) : 691 - 691

← 1 2 3 4 5 →